Ribociclib-induced visual hallucination in a patient with metastatic breast cancer.

Tanju KapaganNilufer BulutSerhat DemirerGokmen Umut Erdem

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

To our knowledge, this is the first reported case of hallucinations caused by ribociclib; notably, it shows that symptoms may develop in the early stage of treatment.

Keyphrases

metastatic breast cancer
early stage
healthcare
case report
high glucose
diabetic rats
endothelial cells
drug induced
combination therapy
physical activity
depressive symptoms